Antonia Calligaro

1.0k total citations
37 papers, 681 citations indexed

About

Antonia Calligaro is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Antonia Calligaro has authored 37 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Rheumatology, 20 papers in Hematology and 13 papers in Immunology. Recurrent topics in Antonia Calligaro's work include Systemic Lupus Erythematosus Research (29 papers), Platelet Disorders and Treatments (13 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Antonia Calligaro is often cited by papers focused on Systemic Lupus Erythematosus Research (29 papers), Platelet Disorders and Treatments (13 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Antonia Calligaro collaborates with scholars based in Italy. Antonia Calligaro's co-authors include Amelia Ruffatti, Teresa Del Ross, Maria Favarò, Marta Tonello, Ariela Hoxha, Piero Marson, Leonardo Punzi, Andrea Doria, S Todesco and Vittorio Pengo and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Lara D. Veeken.

In The Last Decade

Antonia Calligaro

36 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonia Calligaro Italy 16 494 223 222 100 78 37 681
Maria Favarò Italy 17 561 1.1× 275 1.2× 281 1.3× 172 1.7× 130 1.7× 63 867
Adriana Danowski Brazil 9 570 1.2× 307 1.4× 132 0.6× 132 1.3× 96 1.2× 12 688
Teresa Del Ross Italy 17 707 1.4× 387 1.7× 223 1.0× 185 1.9× 143 1.8× 37 880
Bahar Artım-Esen Türkiye 15 498 1.0× 173 0.8× 210 0.9× 72 0.7× 53 0.7× 75 851
Ayşe Çefle Türkiye 17 492 1.0× 137 0.6× 267 1.2× 82 0.8× 122 1.6× 94 1.0k
D Faden Italy 14 500 1.0× 132 0.6× 219 1.0× 115 1.1× 66 0.8× 28 666
Joan Plaza Spain 8 398 0.8× 162 0.7× 118 0.5× 97 1.0× 89 1.1× 8 588
Cecilia Nalli Italy 15 491 1.0× 193 0.9× 240 1.1× 76 0.8× 49 0.6× 48 692
Emilio B. González United States 19 448 0.9× 152 0.7× 211 1.0× 102 1.0× 108 1.4× 46 1.0k
Elaine Baguley United Kingdom 13 614 1.2× 161 0.7× 193 0.9× 87 0.9× 88 1.1× 20 765

Countries citing papers authored by Antonia Calligaro

Since Specialization
Citations

This map shows the geographic impact of Antonia Calligaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Calligaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Calligaro more than expected).

Fields of papers citing papers by Antonia Calligaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Calligaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Calligaro. The network helps show where Antonia Calligaro may publish in the future.

Co-authorship network of co-authors of Antonia Calligaro

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Calligaro. A scholar is included among the top collaborators of Antonia Calligaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Calligaro. Antonia Calligaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruffatti, Amelia, Marta Tonello, Maria Favarò, et al.. (2025). Risk and triggering factors for diffuse alveolar hemorrhage in primary antiphospholipid syndrome. An observational follow-up study and a systematic review of the literature. Seminars in Arthritis and Rheumatism. 72. 152697–152697. 1 indexed citations
2.
3.
Tonello, Marta, Francesco Carta, Antonia Calligaro, et al.. (2024). Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS. Lara D. Veeken. 64(7). 4325–4330. 1 indexed citations
4.
Hoxha, Ariela, Antonia Calligaro, Teresa Del Ross, et al.. (2024). Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study. Journal of Autoimmunity. 144. 103180–103180. 3 indexed citations
5.
Zen, Margherita, Marta Tonello, Maria Favarò, et al.. (2023). Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation. Lara D. Veeken. 63(6). 1733–1738. 2 indexed citations
6.
Ruffatti, Amelia, Marta Tonello, Paolo Macor, et al.. (2021). Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood. 137(21). 2989–2992. 7 indexed citations
7.
Lorenzin, Mariagrazia, Augusta Ortolan, Giacomo Cozzi, et al.. (2021). Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study. Clinical Rheumatology. 40(11). 4569–4580. 21 indexed citations
8.
Tonello, Marta, Antonia Calligaro, Maria Favarò, et al.. (2020). The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics. Archives of Gynecology and Obstetrics. 303(2). 455–461. 9 indexed citations
9.
Ruffatti, Amelia, Marta Tonello, Maria Favarò, et al.. (2020). The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies. Seminars in Arthritis and Rheumatism. 51(1). 28–35. 12 indexed citations
10.
Ruffatti, Amelia, et al.. (2019). Management of pregnant women with antiphospholipid antibodies. Expert Review of Clinical Immunology. 15(4). 347–358. 14 indexed citations
11.
Ruffatti, Amelia, Antonia Calligaro, Carmelo Lacognata, et al.. (2019). Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis. Clinical Rheumatology. 39(4). 1347–1355. 14 indexed citations
12.
Tonello, Marta, Elena De Mattia, Maria Favarò, et al.. (2019). IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers. Thrombosis Research. 177. 157–160. 32 indexed citations
13.
Ruffatti, Amelia, Maria Favarò, Ariela Hoxha, et al.. (2016). Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study. Journal of Reproductive Immunology. 115. 14–19. 35 indexed citations
14.
Ruffatti, Amelia, Maria Favarò, Antonio Brucato, et al.. (2015). Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. Transfusion and Apheresis Science. 53(3). 269–278. 14 indexed citations
15.
Ross, Teresa Del, Amelia Ruffatti, Marta Tonello, et al.. (2015). The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome. Thrombosis Research. 136(5). 883–886. 19 indexed citations
16.
17.
Ross, Teresa Del, Amelia Ruffatti, Marta Tonello, et al.. (2013). Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study. The Journal of Rheumatology. 40(4). 425–429. 40 indexed citations
18.
Rapizzi, Elena, Amelia Ruffatti, Marta Tonello, et al.. (2000). Correction for age of anticardiolipin antibodies cut-off points. Journal of Clinical Laboratory Analysis. 14(3). 87–90. 14 indexed citations
19.
Ruffatti, Amelia, et al.. (1990). Anti-double-stranded DNA antibodies in the healthy elderly: Prevalence and characteristics. Journal of Clinical Immunology. 10(6). 300–303. 36 indexed citations
20.
Ruffatti, Amelia, Laura Rossi, Antonia Calligaro, et al.. (1990). Autoantibodies of Systemic Rheumatic Diseases in the Healthy Elderly. Gerontology. 36(2). 104–111. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Favarò Breakdown of academic impact, for papers by Adriana Danowski Breakdown of academic impact, for papers by Teresa Del Ross Breakdown of academic impact, for papers by Bahar Artım-Esen Breakdown of academic impact, for papers by Ayşe Çefle Breakdown of academic impact, for papers by D Faden Breakdown of academic impact, for papers by Joan Plaza Breakdown of academic impact, for papers by Cecilia Nalli Breakdown of academic impact, for papers by Emilio B. González Breakdown of academic impact, for papers by Elaine Baguley
Rankless by CCL
2026